SYNTERACT OPENS CENTERS OF THERAPEUTIC DEVELOPMENT.

 
FREE EXCERPT

Synteract has created therapeutic centers of development that include some of the most progressive in the biopharma industry: oncology, especially immunotherapy studies, neuro-degenerative disorders, pediatrics, and rare and orphan disease. In addition, Synteract revealed its new market positioning with an updated logo, tagline, and website to reinforce its core capabilities.

Synteract's leadership has been proven in these core development areas, over its nearly 30-year history, through its contributions to more than 240 product approvals. Formal establishment of its new centers of development bring more visibility to Synteract's longstanding, specialized expertise in these complex areas of clinical research.

About Synteract

With 800 staff members across 21 countries, Synteract is a...

To continue reading

FREE SIGN UP